EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Cardiac magnetic resonance biomarkers for cardiovascular complications in diabetes: a systematic review and meta-analysis

Ning Li, Jitao Zhang, Yongyan Wang, Yugeng Li

Frontiers in Cardiovascular Medicine · 28.05.2026 · 13

DOI: 10.3389/fcvm.2026.1817110 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 28.05.2026. Verfasst von Ning Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine II, Qingdao Traditional Chinese Medicine Hospital, Qingdao Hiser Hospital Affiliated of Qingdao University, Qin…. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in diabetes mellitus (DM). Cardiac magnetic resonance (CMR) biomarkers, such as T1 mapping, extracellular volume fraction (ECV), and perfusion indices, have emerged as promising tools for early detection of cardiovascular complications in diabetes.

Methods

We searched for original studies in PubMed, Scopus, Embase, ScienceDirect, and Google Scholar. Included studies enrolled patients with diabetes and were assessed using CMR biomarkers for diagnostic or prognostic outcomes. We extracted data related to study design, study population, CMR techniques, CMR biomarkers, and clinical outcomes. Random-effects meta-analyses were performed for outcomes reported in ≥2 studies.

Results

Nineteen studies ( n = 3,900+ patients) met inclusion criteria. CMR revealed subclinical myocardial changes in diabetic patients, including higher ECV, reduced strain, impaired perfusion, and increased prevalence of late gadolinium enhancement (LGE). Meta-analysis confirmed significantly elevated ECV (SMD = 0.838, p = 0.003), reduced myocardial perfusion reserve index (MPRI, SMD = 1.48, p = 0.033), and higher prevalence of LGE (SMD = 0.583, p < 0.001), while native T1 showed no significant differences, between-study heterogeneity was low across pooled analyses (overall I 2 = 97.4%). The risk of bias was generally low to moderate.

Conclusions

CMR biomarkers for diffuse fibrosis, focal scarring, and microvascular dysfunction provide important insights into myocardial involvement in diabetes and may detect subclinical abnormalities. Nevertheless, due to a small number of studies, the cross-sectional nature of most of the studies, and methodological diversity, these results should be viewed as preliminary. More large-scale, standardized, prospective trials are needed to confirm their contribution to early detection and risk stratification.

Schlagwörter

Stichwörter der Autor:innen

T1 mappingcardiac magnetic resonancediabetes mellitusextracellular volumelate gadolinium enhancementmeta-analysis

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine II, Qingdao Traditional Chinese Medicine Hospital, Qingdao Hiser Hospital Affiliated of Qingdao University, Qingdao, China.
  • Department of Cadre Health Care, Qingdao Traditional Chinese Medicine Hospital, Qingdao Hiser Hospital Affiliated of Qingdao University, Qingdao, China.

Zitieren

APA

Li, N., Zhang, J., Wang, Y., & Li, Y. (2026). Cardiac magnetic resonance biomarkers for cardiovascular complications in diabetes: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1817110

Vancouver

Li N, Zhang J, Wang Y, Li Y. Cardiac magnetic resonance biomarkers for cardiovascular complications in diabetes: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1817110

BibTeX
@article{Li2026,
  author = {Li, Ning and Zhang, Jitao and Wang, Yongyan and Li, Yugeng},
  title = {Cardiac magnetic resonance biomarkers for cardiovascular complications in diabetes: a systematic review and meta-analysis},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1817110}
}
Kostenlos starten →